PharmaDrug (CSE: PHRX) this morning revealed the strategic plans for its Sairiyo Therapeutics subsidiary in relation to the clinical development of...
Vous n'êtes pas connecté
- English
- Français
- عربي
- Español
- Deutsch
- Português
- русский язык
- Català
- Italiano
- Nederlands, Vlaams
- Norsk
- فارسی
- বাংলা
- اردو
- Azərbaycan dili
- Bahasa Indonesia
- Հայերեն
- Ελληνικά
- Bosanski jezik
- українська мова
- Íslenska
- Türkmen, Түркмен
- Türkçe
- Shqip
- Eesti keel
- magyar
- Қазақ тілі
- Kalaallisut ; kalaallit oqaasii
- Lietuvių kalba
- Latviešu valoda
- македонски јазик
- Монгол
- Bahasa Melayu ; بهاس ملايو
- ဗမာစာ
- Slovenščina
- тоҷикӣ ; toğikī ; تاجیکی
- ไทย
- O'zbek ; Ўзбек ; أۇزبېك
- Tiếng Việt
- ភាសាខ្មែរ
- རྫོང་ཁ
- Soomaaliga ; af Soomaali
Maroc - THEDEEPDIVE.CA - A La Une - 19/Aug 13:08
PharmaDrug Joint Venture Receives Approval For Phase 1 Clinical Trial
Pharmadrug Inc (CSE: PHRX) has received approval for its majority owned joint venture, Sairiyo Therapeutics, to process with a Phase 1 clinical study in Australia. The trial aims to assess a reformulated version of oral cepharanthine, referred to as PD-001, as a treatment for cancer and medical countermeasures. The post PharmaDrug Joint Venture Receives Approval For Phase 1 Clinical Trial appeared first on the deep dive.
Articles similaires
Revive Therapeutics Considers Exploring Bucillamine For Treatment Of Monkeypox
thedeepdive.ca - 29/Aug 14:31
Revive Therapeutics (CSE: RVV) is continuing its efforts into evaluating the uses of Bucillamine, disclosing yesterday an update to its The post...
8th MASH Drug Development Summit
pharmiweb.com - 02/Sep 04:49
Madrigal's blockbuster drug gaining FDA approval this March has opened the doors to a wave of therapeutics from Eli Lilly, Boehringer Ingelheim,...
MindBio advances world-first psychedelic microdosing clinical trials
themarketherald.ca - 29/Aug 14:44
MindBio Therapeutics (CSE:MBIO) announces the successful completion of its Phase 1 and 2a clinical trials on depression treatment.
Singapore Airlines gets India investment approval for Air India-Vistara merger
thestar.com.my - 30/Aug 03:13
SINGAPORE Airlines has received Indian government approval for foreign direct investment, clearing a significant hurdle in the merger of airline...
South Korea: Mainstream Renewable Power and Ocean Winds project awarded its EIA approval for 1.1 GW floating offshore wind farm in South Korea
energy pedia.com - 29/Aug 08:17
Mainstream Renewable Power, the pureplay global wind and solar company majority-owned by Aker Horizons, announced that the joint venture KF Wind, a...
Relief Therapeutics presents PKU GOLIKE study results at SSIEM 2024
pharmabiz.com - 03/Sep 00:00
Relief Therapeutics Holding SA, a biopharmaceutical company committed to delivering innovative treatment options for select specialty, unmet and rare...
Westhaven Gold Receives TSX Venture Approval of Claim Package Acquisition From Talisker Resources
financialpost.com - 06/Sep 18:53
VANCOUVER, British Columbia, Sept. 06, 2024 (GLOBE NEWSWIRE) — Westhaven Gold Corp. (TSX-V:WHN) is pleased to announce the Company has received...
Les derniers communiqués
-
Four Seasons to Expand Saudi Arabian Portfolio Alongside Dar Al Omran Company with New Hotel in Madinah
Four Seasons Hotels and Resorts - 07/05/2024
-
Four Seasons Yachts Unveils Inaugural Itineraries to the Caribbean and Mediterranean and a First Look at its 95 Spectacular Suites
Four Seasons Hotels and Resorts - 27/03/2024
-
Visual 01Elevating Excellence: Four Seasons Embarks on the Next Stage of Strategic Global Growth
Four Seasons Hotels and Resorts - 22/01/2024